Akeso, Inc. (9926)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Akeso, Inc. (9926)
Go deeper and ask any question about 9926
Company Performance
Current Price
as of Sep 17, 2024$9.27
P/E Ratio
N/A
Market Cap
$8.02B
Description
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. It operates through the following geographical segments: Chinese Mainland, USA, and Other Regions. The company was founded by Yu Xia, Peng Zhang, Baiyong Li, and Zhongmin Wang in March 2012 and is headquartered in Zhongshan, China.
Metrics
Overview
- HQZhongshan, GD
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- Ticker9926
- Price$9.265551+0.86%
Trading Information
- Market Cap$8.02B
- Float67.46%
- Average Daily Volume (1m)10,032,617
- Average Daily Volume (3m)6,451,003
- EPS$2.68
Company
- Revenue$5.00B
- Rev Growth (1yr)401.75%
- Net Income$2.24B
- Gross Margin93.91%
- EBITDA Margin48.33%
- EBITDA$2.42B
- EV$36.59B
- EV/Revenue7.31
- P/EN/A
- P/S30.05
Documents
Factset Street Account
Factset